↓ Skip to main content

Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG…

Overview of attention for article published in Breast Cancer Research and Treatment, November 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG)
Published in
Breast Cancer Research and Treatment, November 2014
DOI 10.1007/s10549-014-3202-5
Pubmed ID
Authors

Emmanouil Saloustros, Nikolaos Malamos, Ioannis Boukovinas, Stylianos Kakolyris, Charalampos Kouroussis, Athanasios Athanasiadis, Nikolaos Ziras, Nikolaos Kentepozidis, Parisis Makrantonakis, Aristidis Polyzos, Charalampos Christophyllakis, Vassilios Georgoulias, Dimitrios Mavroudis

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Greece 1 3%
Unknown 38 95%

Demographic breakdown

Readers by professional status Count As %
Other 4 10%
Student > Bachelor 4 10%
Student > Ph. D. Student 3 8%
Researcher 3 8%
Student > Doctoral Student 2 5%
Other 7 18%
Unknown 17 43%
Readers by discipline Count As %
Medicine and Dentistry 14 35%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Nursing and Health Professions 2 5%
Psychology 2 5%
Sports and Recreations 1 3%
Other 1 3%
Unknown 18 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 July 2018.
All research outputs
#7,536,586
of 22,994,508 outputs
Outputs from Breast Cancer Research and Treatment
#1,673
of 4,677 outputs
Outputs of similar age
#76,715
of 232,550 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#20
of 48 outputs
Altmetric has tracked 22,994,508 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,677 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 232,550 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.